ATE228372T1 - Hcg und derivate als matrixmetalloprotease- inhibitoren - Google Patents

Hcg und derivate als matrixmetalloprotease- inhibitoren

Info

Publication number
ATE228372T1
ATE228372T1 AT97934545T AT97934545T ATE228372T1 AT E228372 T1 ATE228372 T1 AT E228372T1 AT 97934545 T AT97934545 T AT 97934545T AT 97934545 T AT97934545 T AT 97934545T AT E228372 T1 ATE228372 T1 AT E228372T1
Authority
AT
Austria
Prior art keywords
hcg
derivatives
matrix metalloprotease
metalloprotease inhibitors
inhibitors
Prior art date
Application number
AT97934545T
Other languages
English (en)
Inventor
Adriana Albini
Giorgia Orengo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE228372T1 publication Critical patent/ATE228372T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97934545T 1996-08-07 1997-07-25 Hcg und derivate als matrixmetalloprotease- inhibitoren ATE228372T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000566A IT1284876B1 (it) 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi
PCT/EP1997/004053 WO1998005353A1 (en) 1996-08-07 1997-07-25 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS

Publications (1)

Publication Number Publication Date
ATE228372T1 true ATE228372T1 (de) 2002-12-15

Family

ID=11404385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934545T ATE228372T1 (de) 1996-08-07 1997-07-25 Hcg und derivate als matrixmetalloprotease- inhibitoren

Country Status (14)

Country Link
US (1) US6444639B2 (de)
EP (1) EP0920330B1 (de)
JP (1) JP3996952B2 (de)
AR (1) AR009013A1 (de)
AT (1) ATE228372T1 (de)
AU (1) AU732972B2 (de)
CA (1) CA2262582C (de)
DE (1) DE69717463T2 (de)
DK (1) DK0920330T3 (de)
ES (1) ES2183205T3 (de)
IL (1) IL128399A (de)
IT (1) IT1284876B1 (de)
PT (1) PT920330E (de)
WO (1) WO1998005353A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2556266A1 (en) 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Use of luteinizing hormone (lh), and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
CA2582567A1 (en) 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
WO2007106987A1 (en) 2006-03-17 2007-09-27 Stem Cell Therapeutics Corp. Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
US20170136093A1 (en) * 2014-07-15 2017-05-18 Zietchick Research Institute, Llc Method for preventing or treating ocular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
AU723646B2 (en) 1995-10-16 2000-08-31 Laboratoires Serono Sa Use of human chorionic gonadotropin in the treatment of Kaposi's Sarcoma
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
CA2262582A1 (en) 1998-02-12
DK0920330T3 (da) 2002-12-30
AU3771197A (en) 1998-02-25
US20010006940A1 (en) 2001-07-05
ITRM960566A0 (de) 1996-08-07
US6444639B2 (en) 2002-09-03
EP0920330B1 (de) 2002-11-27
DE69717463T2 (de) 2003-07-10
IL128399A (en) 2006-10-05
IT1284876B1 (it) 1998-05-22
IL128399A0 (en) 2000-01-31
WO1998005353A1 (en) 1998-02-12
AR009013A1 (es) 2000-03-08
AU732972B2 (en) 2001-05-03
DE69717463D1 (de) 2003-01-09
ES2183205T3 (es) 2003-03-16
JP2000516582A (ja) 2000-12-12
CA2262582C (en) 2009-02-24
JP3996952B2 (ja) 2007-10-24
ITRM960566A1 (it) 1998-02-07
EP0920330A1 (de) 1999-06-09
PT920330E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
ATE231132T1 (de) Heterocyclische metalloprotease inhibitoren
EE9900171A (et) Heteroarüülsuktsiinamiidid ja nende kasutamine metalloproteinaaside inhibiitoritena
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
DK0923561T3 (da) Heterocykliske metalloproteaseinhibitorer
DE69820906D1 (de) Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
NO972307D0 (no) Matriksmetallproteaseinhibitorer
FI990466A0 (fi) Aktivaattorit ja laite
ATE277895T1 (de) 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
ATE214693T1 (de) Aminoguanidine und alkoxyguanidine als protease- hemmer
BR9710381A (pt) Inibidores de metaloproteases de matriz - base de fosfinato
ATE272062T1 (de) Spirocyclisch metalloprotease inhibitoren
DE69903143D1 (de) Chromanon und thiochromanon derivate
PT892796E (pt) Derivados de isatina como inibidores de acetilcolinesterase e analgesicos
NO985227L (no) Alkylaminobenzothiazol og -benzoksazol - derivater
BR9709902A (pt) Inibidores de metalo-proteinase de matriz
DE69702751D1 (de) Dipeptidische benzamidine als kininogenasen-inhibitoren
HUP9904165A3 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase and use thereof
ATE210112T1 (de) Substituierte 4-biphenyl-4- hydroxybuttersäurederivate als matrix metallprotease inhibitoren
DE69708629D1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
ATE228372T1 (de) Hcg und derivate als matrixmetalloprotease- inhibitoren
ATE205822T1 (de) Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren
ATE229497T1 (de) Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren
DE69831427D1 (de) Benzo(c)quinolizinderivative und deren verwendung als 5 alpha-reduktase-hemmer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0920330

Country of ref document: EP

EEFA Change of the company name